A DNA synthesis company using a next-generation silicon-based technology platform.
The turnaround time for orders is still relatively long compared to other lab-based methods, especially for smaller amounts of DNA. Therefore, in certain instances it is more reasonable for researchers and companies to utilize traditional cloning methods depending on the genes needed for experiments. Slow turnaround time for smaller orders is the primary reason Ginkgo Bioworks acquired Gen9Gen9, which brought that function in-house.
No more activity to show.